F16.150 Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions

Name of the Condition

• Hallucinogen Abuse with Hallucinogen-Induced Psychotic Disorder with Delusions
• Medical Term: ICD-10-CM F16.150

Summary

Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions involves the problematic use of hallucinogenic substances that leads to the development of psychotic symptoms, specifically delusions, which are not better explained by another condition. This condition requires clinical evaluation to distinguish substance-induced symptoms from primary psychotic disorders.

Causes

Hallucinogen abuse typically arises from the recreational use of substances like LSD, psilocybin mushrooms, or PCP. The psychotic disorder is directly caused by the pharmacological effects of these substances, which can disrupt neurotransmitter systems and trigger acute or persistent psychotic symptoms.

Risk Factors

• Heavy or frequent use of hallucinogens
• Pre-existing vulnerability to psychosis (e.g., family history of schizophrenia)
• High-dose exposure or use of potent hallucinogens
• Concurrent use of other substances (e.g., stimulants or alcohol)

Symptoms

• Persistent delusions (fixed false beliefs)
• Visual, auditory, or tactile hallucinations
• Disorganized thinking or speech
• Paranoia or suspiciousness
• Impaired reality testing
• Emotional dysregulation (e.g., agitation or flattened affect)

Diagnosis

Diagnosis is primarily clinical, based on a patient's history of substance use and reported symptoms. Mental health assessments may be used to evaluate the impact of use, and toxicology screens can confirm the presence of hallucinogens. The presence of delusions must be directly attributable to hallucinogen use and not better explained by another condition.

Treatment Options

• Therapy: Cognitive behavioral therapy (CBT) to address thought patterns and substance use behaviors.
• Medication: Antipsychotics may be used to manage acute psychotic symptoms, with careful monitoring for substance interactions.
• Support Groups: Participation in groups like Narcotics Anonymous to gain peer support.
• Education: Patient education on the risks of hallucinogen use and strategies to avoid relapse.

Prognosis and Follow-Up

Prognosis depends on the severity of use, duration of symptoms, and response to treatment. Early intervention improves outcomes. Follow-up care should include regular monitoring for symptom recurrence and substance use, with adjustments to treatment as needed.

Complications

• Persistent psychotic symptoms
• Worsening of pre-existing mental health conditions
• Social or occupational impairment
• Increased risk of accidental injury due to impaired judgment

Lifestyle & Prevention

• Avoiding hallucinogenic substances entirely
• Engaging in stress-reduction techniques (e.g., mindfulness, exercise)
• Building a strong support network
• Seeking help for underlying mental health issues

When to Seek Professional Help

Seek immediate medical attention if experiencing severe delusions, hallucinations, or impaired reality testing. Contact a healthcare provider if substance use is causing distress or interfering with daily life.

Tips for Medical Coders

Document the presence of delusions and their direct link to hallucinogen use. Ensure the diagnosis differentiates substance-induced symptoms from primary psychotic disorders. Include details on substance type, frequency, and duration of use to support code assignment.